Fujian Cosunter Pharmaceutical Hits Day Low Amid Price Pressure at CNY 115.26

Fujian Cosunter Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 8.17% on February 24, 2026. The stock reached an intraday low of CNY 115.26, reflecting a challenging trading environment. In terms of performance metrics, the company has shown a stark contrast in its short-term and long-term results. Over the past week, Fujian Cosunter's stock has decreased by 9.18%, while it has demonstrated a remarkable annual growth of 273.25%. However, this growth is juxtaposed with concerning financial indicators, including a high debt-to-equity ratio of 0.50 and a return on equity of -56.81%. The company's operating losses and weak long-term fundamental strength raise questions about its financial stability. Despite a market capitalization of CNY 16,397 million, the stock's performance has been volatile, particularly in the context of the broader China Shanghai Composite, which has only declined by 1.26% today. As Fujian Cosunter navigates these challenges, its financial metrics will be crucial in assessing its market position moving forward.